Jay Rubinstein
Pediatric Otolaryngology · Seattle, WANPI 1790860518
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $61,267 of the $69,892 with a category attached, or 87.7%. Advanced Bionics, LLC accounts for 84.9% of it on its own, with 3 other manufacturers making up the rest. 2025 is the largest year on record at $64,721, more than ten times the $3,381 reported in 2019.
Across 23 payments — averaging $3038.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Advanced Bionics, LLC$59K
- Regeneron$10K
- Med-el Corporation$151
- Iotamotion, Inc.$28
Across 50 payments — averaging $2135.30 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Regeneron$107K
What the payments were for
- Consulting fees$61,26788%
- Travel & lodging$8,15412%
- Food & beverage$4711%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Advanced Bionics, LLC | 13 | $59,347 |
| Regeneron | 8 | $10,367 |
| Med-el Corporation | 1 | $151 |
| Iotamotion, Inc. | 1 | $28 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few pediatric otolaryngology providers in Washingtonto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid | 26 | $232 |
Paid to pharmacies, not to this prescriber.
Other pediatric otolaryngology in Seattle
- Jonathan PerkinsSeattle$6K
- Sheng ZhouSeattle$3K
- Randall BlySeattle$2K
- Theresa KimSeattle$587
- Kathleen SieSeattle$532
- Scott ManningSeattle$499
- Juliana Bonilla-VelezSeattle$222
- Emmanuel JaureguiSeattle$81
- Kaitlyn ZennerSeattle$65
- Tianjie ShenSeattle$43
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.